Trium Capital »

Aclaris Therapeutics shares owned by Trium Capital

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Trium Capital from 13F filings

Historical chart of Trium Capital investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Trium Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Trium Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.2M 1.9M 1.15
2024-06-30 $2.1M 1.9M 1.10